The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer

Chiara Avellini, Caterina Licini, Raffaella Lazzarini, Rosaria Gesuita, Emanuela Guerra, Giovanni Tossetta, Clara Castellucci, Stefano Raffaele Giannubilo, Antonio Procopio, Saverio Alberti, Roberta Mazzucchelli, Fabiola Olivieri, Daniela Marzioni

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Human trophoblast cell surface antigen 2 (Trop-2) is a 40-kDa transmembrane glycoprotein that was first identified as a marker of human trophoblast cells. Trop-2 acts on cell proliferation, adhesion, and migration by activating a number of intracellular signalling pathways. Elevated Trop-2 expression has been demonstrated in several types of cancer and correlated with aggressiveness and poor prognosis. Since no data are available on Trop-2 in bladder cancer (BC), the purpose of the study was to determine its levels in tissue specimens from normal individuals and patients with BC at different stages. Moreover, since according to recent evidence Trop-2 is a miR-125b target, miR-125b expression was also assessed in tissue specimens. Finally, the effect of the Trop-2/miR-125b axis on the proliferation and migration of BC cells was evaluated in vitro.The Trop-2/miR-125b axis was seen to be differentially expressed in normal urothelium, non-invasive BC and invasive BC tissue. Significant miR-125b down-regulation was associated with a significant increase in Trop-2 protein levels in BC tissue and correlated with disease severity. In vitro analysis confirmed the role of miR-125b in down-modulation of Trop-2 protein levels and showed that Trop-2/miR-125b axis affects cellular proliferation in bladder tissue.In conclusion, our findings highlight a role for the Trop-2/miR-125b axis in BC progression and suggest Trop-2 and miR-125b as diagnostic/prognostic marker candidates as well as druggable targets for innovative therapeutic approaches.

Original languageEnglish
Pages (from-to)58642-58653
Number of pages12
JournalOncotarget
Volume8
Issue number35
DOIs
Publication statusPublished - Apr 25 2017

Fingerprint

Trophoblasts
Surface Antigens
Urinary Bladder Neoplasms
Cell Proliferation
Urothelium
Cell Adhesion
Cell Movement
Glycoproteins
Urinary Bladder
Proteins
Down-Regulation

Keywords

  • Journal Article

Cite this

Avellini, C., Licini, C., Lazzarini, R., Gesuita, R., Guerra, E., Tossetta, G., ... Marzioni, D. (2017). The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer. Oncotarget, 8(35), 58642-58653. https://doi.org/10.18632/oncotarget.17407

The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer. / Avellini, Chiara; Licini, Caterina; Lazzarini, Raffaella; Gesuita, Rosaria; Guerra, Emanuela; Tossetta, Giovanni; Castellucci, Clara; Giannubilo, Stefano Raffaele; Procopio, Antonio; Alberti, Saverio; Mazzucchelli, Roberta; Olivieri, Fabiola; Marzioni, Daniela.

In: Oncotarget, Vol. 8, No. 35, 25.04.2017, p. 58642-58653.

Research output: Contribution to journalArticle

Avellini, C, Licini, C, Lazzarini, R, Gesuita, R, Guerra, E, Tossetta, G, Castellucci, C, Giannubilo, SR, Procopio, A, Alberti, S, Mazzucchelli, R, Olivieri, F & Marzioni, D 2017, 'The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer', Oncotarget, vol. 8, no. 35, pp. 58642-58653. https://doi.org/10.18632/oncotarget.17407
Avellini C, Licini C, Lazzarini R, Gesuita R, Guerra E, Tossetta G et al. The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer. Oncotarget. 2017 Apr 25;8(35):58642-58653. https://doi.org/10.18632/oncotarget.17407
Avellini, Chiara ; Licini, Caterina ; Lazzarini, Raffaella ; Gesuita, Rosaria ; Guerra, Emanuela ; Tossetta, Giovanni ; Castellucci, Clara ; Giannubilo, Stefano Raffaele ; Procopio, Antonio ; Alberti, Saverio ; Mazzucchelli, Roberta ; Olivieri, Fabiola ; Marzioni, Daniela. / The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer. In: Oncotarget. 2017 ; Vol. 8, No. 35. pp. 58642-58653.
@article{e084854b3d6d44ba9a26bb8224a79ffb,
title = "The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer",
abstract = "Human trophoblast cell surface antigen 2 (Trop-2) is a 40-kDa transmembrane glycoprotein that was first identified as a marker of human trophoblast cells. Trop-2 acts on cell proliferation, adhesion, and migration by activating a number of intracellular signalling pathways. Elevated Trop-2 expression has been demonstrated in several types of cancer and correlated with aggressiveness and poor prognosis. Since no data are available on Trop-2 in bladder cancer (BC), the purpose of the study was to determine its levels in tissue specimens from normal individuals and patients with BC at different stages. Moreover, since according to recent evidence Trop-2 is a miR-125b target, miR-125b expression was also assessed in tissue specimens. Finally, the effect of the Trop-2/miR-125b axis on the proliferation and migration of BC cells was evaluated in vitro.The Trop-2/miR-125b axis was seen to be differentially expressed in normal urothelium, non-invasive BC and invasive BC tissue. Significant miR-125b down-regulation was associated with a significant increase in Trop-2 protein levels in BC tissue and correlated with disease severity. In vitro analysis confirmed the role of miR-125b in down-modulation of Trop-2 protein levels and showed that Trop-2/miR-125b axis affects cellular proliferation in bladder tissue.In conclusion, our findings highlight a role for the Trop-2/miR-125b axis in BC progression and suggest Trop-2 and miR-125b as diagnostic/prognostic marker candidates as well as druggable targets for innovative therapeutic approaches.",
keywords = "Journal Article",
author = "Chiara Avellini and Caterina Licini and Raffaella Lazzarini and Rosaria Gesuita and Emanuela Guerra and Giovanni Tossetta and Clara Castellucci and Giannubilo, {Stefano Raffaele} and Antonio Procopio and Saverio Alberti and Roberta Mazzucchelli and Fabiola Olivieri and Daniela Marzioni",
year = "2017",
month = "4",
day = "25",
doi = "10.18632/oncotarget.17407",
language = "English",
volume = "8",
pages = "58642--58653",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "35",

}

TY - JOUR

T1 - The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer

AU - Avellini, Chiara

AU - Licini, Caterina

AU - Lazzarini, Raffaella

AU - Gesuita, Rosaria

AU - Guerra, Emanuela

AU - Tossetta, Giovanni

AU - Castellucci, Clara

AU - Giannubilo, Stefano Raffaele

AU - Procopio, Antonio

AU - Alberti, Saverio

AU - Mazzucchelli, Roberta

AU - Olivieri, Fabiola

AU - Marzioni, Daniela

PY - 2017/4/25

Y1 - 2017/4/25

N2 - Human trophoblast cell surface antigen 2 (Trop-2) is a 40-kDa transmembrane glycoprotein that was first identified as a marker of human trophoblast cells. Trop-2 acts on cell proliferation, adhesion, and migration by activating a number of intracellular signalling pathways. Elevated Trop-2 expression has been demonstrated in several types of cancer and correlated with aggressiveness and poor prognosis. Since no data are available on Trop-2 in bladder cancer (BC), the purpose of the study was to determine its levels in tissue specimens from normal individuals and patients with BC at different stages. Moreover, since according to recent evidence Trop-2 is a miR-125b target, miR-125b expression was also assessed in tissue specimens. Finally, the effect of the Trop-2/miR-125b axis on the proliferation and migration of BC cells was evaluated in vitro.The Trop-2/miR-125b axis was seen to be differentially expressed in normal urothelium, non-invasive BC and invasive BC tissue. Significant miR-125b down-regulation was associated with a significant increase in Trop-2 protein levels in BC tissue and correlated with disease severity. In vitro analysis confirmed the role of miR-125b in down-modulation of Trop-2 protein levels and showed that Trop-2/miR-125b axis affects cellular proliferation in bladder tissue.In conclusion, our findings highlight a role for the Trop-2/miR-125b axis in BC progression and suggest Trop-2 and miR-125b as diagnostic/prognostic marker candidates as well as druggable targets for innovative therapeutic approaches.

AB - Human trophoblast cell surface antigen 2 (Trop-2) is a 40-kDa transmembrane glycoprotein that was first identified as a marker of human trophoblast cells. Trop-2 acts on cell proliferation, adhesion, and migration by activating a number of intracellular signalling pathways. Elevated Trop-2 expression has been demonstrated in several types of cancer and correlated with aggressiveness and poor prognosis. Since no data are available on Trop-2 in bladder cancer (BC), the purpose of the study was to determine its levels in tissue specimens from normal individuals and patients with BC at different stages. Moreover, since according to recent evidence Trop-2 is a miR-125b target, miR-125b expression was also assessed in tissue specimens. Finally, the effect of the Trop-2/miR-125b axis on the proliferation and migration of BC cells was evaluated in vitro.The Trop-2/miR-125b axis was seen to be differentially expressed in normal urothelium, non-invasive BC and invasive BC tissue. Significant miR-125b down-regulation was associated with a significant increase in Trop-2 protein levels in BC tissue and correlated with disease severity. In vitro analysis confirmed the role of miR-125b in down-modulation of Trop-2 protein levels and showed that Trop-2/miR-125b axis affects cellular proliferation in bladder tissue.In conclusion, our findings highlight a role for the Trop-2/miR-125b axis in BC progression and suggest Trop-2 and miR-125b as diagnostic/prognostic marker candidates as well as druggable targets for innovative therapeutic approaches.

KW - Journal Article

U2 - 10.18632/oncotarget.17407

DO - 10.18632/oncotarget.17407

M3 - Article

VL - 8

SP - 58642

EP - 58653

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 35

ER -